IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
This Quarter Return
+13.03%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$260M
AUM Growth
+$260M
(+1.6%)
Cap. Flow
-$9.69M
Cap. Flow
% of AUM
-3.72%
Top 10 Holdings %
Top 10 Hldgs %
46.09%
Holding
68
New
5
Increased
11
Reduced
11
Closed
14
Top Buys
| 1 |
Illumina
ILMN
|
$12.6M |
| 2 |
SPPI
Spectrum Pharmaceuticals Inc
SPPI
|
$6.29M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
$5.4M |
| 4 |
Incyte
INCY
|
$3.55M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$3.01M |
Top Sells
| 1 |
SHPG
Shire pic
SHPG
|
$12.5M |
| 2 |
SAGE
Sage Therapeutics
SAGE
|
$4.3M |
| 3 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$4.01M |
| 4 |
Gilead Sciences
GILD
|
$2.91M |
| 5 |
Biogen
BIIB
|
$2.73M |
Sector Composition
| 1 | Healthcare | 93.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Neurocrine Biosciences
NBIX
$13.8B
| $16.1M | 6.17% | 163,500 +9,500 | +6% | +$933K |
|
|
CELG
2
DELISTED
Celgene Corp
CELG
| $15.1M | 5.78% | 189,522 -16,000 | -8% | -$1.27M |
|
3
Vertex Pharmaceuticals
VRTX
$100B
| $14.1M | 5.43% | 83,222 +15,000 | +22% | +$2.55M |
|
|
4
Illumina
ILMN
$15.8B
| $12.6M | 4.83% | +45,000 | New | +$12.6M |
|
|
ARRY
5
DELISTED
Array Biopharma Inc
ARRY
| $11.6M | 4.47% | 694,500 -157,000 | -18% | -$2.63M |
|
6
Regeneron Pharmaceuticals
REGN
$61.5B
| $10.8M | 4.15% | 31,330 -4,700 | -13% | -$1.62M |
|
|
7
Biogen
BIIB
$19.4B
| $10.5M | 4.04% | 36,208 -9,400 | -21% | -$2.73M |
|
|
ALXN
8
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $10.1M | 3.89% | 81,641 +9,200 | +13% | +$1.14M |
|
9
Exelixis
EXEL
$10.1B
| $9.57M | 3.67% | 444,534 +56,200 | +14% | +$1.21M |
|
|
ADMS
10
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $9.55M | 3.67% | 370,000 | – | – |
|
|
11
BioMarin Pharmaceuticals
BMRN
$11.2B
| $9.16M | 3.52% | 97,284 +32,000 | +49% | +$3.01M |
|
|
12
Incyte
INCY
$16.5B
| $8.44M | 3.24% | 125,975 +53,000 | +73% | +$3.55M |
|
|
STML
13
DELISTED
Stemline Therapeutics, Inc.
STML
| $7.86M | 3.02% | 492,930 | – | – |
|
14
Ligand Pharmaceuticals
LGND
$3.15B
| $7.25M | 2.78% | 35,000 -7,000 | -17% | -$1.45M |
|
15
Halozyme
HALO
$8.56B
| $7.23M | 2.78% | 428,633 +70,000 | +20% | +$1.18M |
|
|
SAGE
16
DELISTED
Sage Therapeutics
SAGE
| $6.73M | 2.58% | 42,996 -27,500 | -39% | -$4.3M |
|
|
17
Gilead Sciences
GILD
$140B
| $6.4M | 2.46% | 90,284 -41,000 | -31% | -$2.91M |
|
|
SPPI
18
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $6.29M | 2.41% | +300,000 | New | +$6.29M |
|
|
ABMD
19
DELISTED
Abiomed Inc
ABMD
| $5.4M | 2.07% | +13,200 | New | +$5.4M |
|
20
Ionis Pharmaceuticals
IONS
$6.8B
| $5.27M | 2.02% | 126,500 | – | – |
|
|
SHPG
21
DELISTED
Shire pic
SHPG
| $4.22M | 1.62% | 25,000 -74,000 | -75% | -$12.5M |
|
|
XENT
22
DELISTED
Intersect ENT, Inc
XENT
| $4.19M | 1.61% | 112,000 +75,000 | +203% | +$2.81M |
|
|
ASXC
23
DELISTED
Asensus Surgical, Inc.
ASXC
| $3.82M | 1.47% | 889,082 | – | – |
|
24
Alnylam Pharmaceuticals
ALNY
$58.5B
| $3.62M | 1.39% | 36,800 | – | – |
|
25
Sarepta Therapeutics
SRPT
$1.78B
| $3.57M | 1.37% | 27,000 | – | – |
|